Facephi Biometria SA (ES:FACE)
BME:FACE
Want to see ES:FACE full AI Analyst Report?
Top Page
Facephi Biometria SA
(BME:FACE)
Select Model
Select Model
Rating:50Neutral
Price Target:
€2.00
▼(-20.95% Downside)
Action:Reiterated
Date:05/27/26
The score is driven primarily by improving financial performance in 2025 (return to profitability, stronger operating cash flow, and better leverage), but is held back by negative free cash flow and a still-thin net margin. Technicals remain bearish with the stock below major moving averages and negative MACD, and valuation is a notable headwind given the very high P/E and no dividend support.
Positive Factors
Return to profitability & revenue growth
A return to positive EBIT and net income alongside 20.7% revenue growth in 2025 indicates the core biometric licensing and services model can scale profitably. This durable improvement supports reinvestment, reduces refinancing pressure, and improves runway for strategic initiatives over the next several quarters.
Negative Factors
Negative free cash flow
Persistently negative free cash flow (~-€1.4M) means capital expenditures or working capital use still outpace operating cash inflows. Over months this limits the firm's ability to self-fund growth initiatives, may force external financing, and constrains shareholder return capacity if not reversed.
Read all positive and negative factors
Positive Factors
Negative Factors
Return to profitability & revenue growth
A return to positive EBIT and net income alongside 20.7% revenue growth in 2025 indicates the core biometric licensing and services model can scale profitably. This durable improvement supports reinvestment, reduces refinancing pressure, and improves runway for strategic initiatives over the next several quarters.
Read all positive factors
Facephi Biometria SA (FACE) vs. iShares MSCI Spain ETF (EWP)
Market Cap
€59.78M
Dividend YieldN/A
Average Volume (3M)21.10K
Price to Earnings (P/E)162.3
Beta (1Y)0.18
Revenue GrowthN/A
EPS GrowthN/A
CountryES
Employees233
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.01
Shares Outstanding26,624,086
10 Day Avg. Volume10,893
30 Day Avg. Volume21,097
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)3.07
Price to Sales (P/S)1.86
P/FCF Ratio-47.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)€46.10M
Facephi Biometria SA Business Overview & Revenue Model
Company Description
Facephi Biometria, S.A. provides biometric facial recognition technology solutions primarily for banking sector in Latin America, the United States, Asia, and internationally. Its products include Facephi Beyond Biometrics, a multi-biometric solut...
How the Company Makes Money
Facephi generates revenue primarily by selling and licensing its biometric and digital-identity software to enterprise and institutional customers, and by providing implementation and ongoing services that support those deployments. Key revenue st...
Facephi Biometria SA Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
64
Positive
Cash Flow
48
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 35.98M | 28.88M | 29.32M | 22.28M | 13.16M |
| Gross Profit | 22.75M | 13.21M | 25.90M | 22.92M | 13.46M |
| EBITDA | 7.90M | -220.15K | -4.77M | 3.30M | 821.13K |
| Net Income | 368.70K | -8.88M | -4.31M | 1.11M | -553.90K |
Balance Sheet | |||||
| Total Assets | 48.01M | 49.71M | 45.71M | 32.25M | 18.36M |
| Cash, Cash Equivalents and Short-Term Investments | 2.21M | 5.70M | 2.90M | 2.05M | 1.39M |
| Total Debt | 7.20M | 10.18M | 12.96M | 7.83M | 6.22M |
| Total Liabilities | 26.22M | 30.52M | 25.67M | 17.04M | 9.65M |
| Stockholders Equity | 21.79M | 19.19M | 20.04M | 15.21M | 8.71M |
Cash Flow | |||||
| Free Cash Flow | -1.42M | -4.53M | -664.63K | -7.88M | -6.15M |
| Operating Cash Flow | 7.34M | 724.43K | 853.21K | -5.82M | -3.60M |
| Investing Cash Flow | -8.76M | -5.28M | -9.83M | -2.20M | -2.14M |
| Financing Cash Flow | -919.49K | 7.56M | 9.54M | 8.60M | 1.30M |
Facephi Biometria SA Technical Analysis
Neutral
2.53
Price Trends
2.21
Positive
2.32
Negative
2.43
Negative
Market Momentum
-0.02
Negative
55.02
Neutral
90.13
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:FACE, the sentiment is Neutral. The current price of 2.53 is above the 20-day moving average (MA) of 2.20, above the 50-day MA of 2.21, and above the 200-day MA of 2.43, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 55.02 is Neutral, neither overbought nor oversold. The STOCH value of 90.13 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ES:FACE.
Facephi Biometria SA Peers Comparison
UnderperformOutperform
Sector (55)
ES:FACE
Facephi Biometria SA
2.26
-0.07
-3.00%
ES:IZER
Izertis SA
8.54
-0.58
-6.36%
ES:SAI
Substrate Artificial Intelligence SA
0.03
-0.08
-70.43%
ES:AI
Airtificial Intelligence Structures SA
0.09
-0.03
-24.17%
ES:SCO
Seresco SA
6.40
-0.26
-3.90%
ES:ATSI
Aplicaciones y Tratamiento de Sistemas, S.A.
4.26
0.61
16.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.